Drug Shortage Report for MEDROXY-2.5
Report ID | 116357 |
Drug Identification Number | 02253550 |
Brand name | MEDROXY-2.5 |
Common or Proper name | MEDROXY |
Company Name | PRO DOC LIMITEE |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MEDROXYPROGESTERONE ACETATE |
Strength(s) | 2.5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 500 |
ATC code | G03DA |
ATC description | PROGESTOGENS |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-06-02 |
Estimated end date | Unknown |
Actual end date | 2020-07-17 |
Shortage status | Resolved |
Updated date | 2020-07-18 |
Company comments | Looking for an alternate source of supply Recherche d'une source alternative d'approvisionnement |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-07-18 | English | Compare |
v5 | 2020-07-17 | French | Compare |
v4 | 2020-07-17 | English | Compare |
v3 | 2020-06-03 | English | Compare |
v2 | 2020-06-02 | French | Compare |
v1 | 2020-06-02 | English | Compare |
Showing 1 to 6 of 6